 |
Journal articles
Interleukin‐22 in urinary tract disease – new experimental directions
Abstract : Interleukin (IL)-22 is expressed by immune cells in the urinary tract and IL-22 receptor is expressed in urothelium and renal tubule cells. IL-22 can be specifically targeted in the urinary tract or conditionally depleted in mice and targeted therapeutically in humans.
Cited literature [14 references]
https://hal-pasteur.archives-ouvertes.fr/pasteur-02899702
Contributor : Marie-Christine Vougny <>
Submitted on : Wednesday, July 15, 2020 - 2:23:58 PM
Last modification on : Monday, July 20, 2020 - 11:08:58 AM
Contributor : Marie-Christine Vougny <>
Submitted on : Wednesday, July 15, 2020 - 2:23:58 PM
Last modification on : Monday, July 20, 2020 - 11:08:58 AM
File
Interleukin22 in urinary tract...
Publication funded by an institution
Licence
Distributed under a Creative Commons Attribution 4.0 International License